← FDA ENFORCEMENT
F-0455-2025Class II

Iovate Health Sciences USA Inc.

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
Iovate Health Sciences USA Inc.
Product type
Food / supplement / cosmetic
Status
Terminated
Report date
2025-02-05
Distribution
Domestic and foreign distribution:NC, CA, TX, NJ, VA, NV, PA, IN, NY, CA, IL,MS, KY, MI,SC, WA, CT, FL, OH, WI, DE, LA, TN, MO, UT, KH, GA, KS, CO, IA, AZ, OR. Foreign distribution: ZA, PH, IS, KZ, AE
Firm state
DE
Product quantity
Total 163,248 units
Initiated by
Voluntary: Firm initiated
Reason for recall

Presence of cathine in product

Product description

Alpha Test 120 count Black labeled plastic bottle, 12 bottles per case of 120 count capsules each per bottle, Store in a cool, dry place (60 F to 80 F), UPC 6-31656-60676-8, SKU0001191, SKU0002075

Code / lot info

Expiration Date and Lot Codes: March 21, 2027 (Lots 24A125, 24B059, 24B060) March 22, 2027 (Lot 24C112) July 3, 2027 (Lots 24F164, 24G112) July 4, 2027 (Lot 24E288) July 5, 2027 (Lots 24G243, 24H207)

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →